Pathogenicity of thermolabile methylenetetrahydrofolate reductase for vascular dementia

被引:49
作者
Yoo, JH
Choi, GD
Kang, SS
机构
[1] Sungkyunkwan Univ, Sch Med,Samsung Biomed Res Inst, Clin Res Ctr, Samsung Med Ctr,Dept Family Med, Seoul 135710, South Korea
[2] Inchon Eun Hye Hosp, Neuropsychiat Hosp, Dept Geriatr Med, Inchon, South Korea
[3] Rush Presbyterian St Lukes Med Ctr, Chicago, IL 60612 USA
[4] Rush Med Coll, Dept Pediat, Genet Sect, Chicago, IL 60612 USA
关键词
methylenetetrahydrofolate reductase; genes; cerebral infarction; hyperhomocyst(e)inemia; vascular dementia;
D O I
10.1161/01.ATV.20.8.1921
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Although the major biochemical abnormality due to methylenetetrahydrofolate reductase (MTHFR) deficiency is hyperhomocyst(e)inemia, its pathogenicity appears to involve more than homocysteine toxicity. In patients with severe MTHFR deficiency, a metabolite(s) other than hyperhomocyst(e)inemia also appears to be associated with its clinical manifestation in cerebrovascular disease. To elucidate the specific role of the TT genotype of MTHFR in the development of cerebral infarction with and without cognitive impairment, we determined the prevalence of hyperhomocyst(e)inemia and the C677T genotypes of MTHFR in 143 patients with vascular dementia, 122 patients with cerebral infarction, and 217 healthy subjects matched for age and sex. Prevalence of hyperhomocyst(e)inemia [homocyst(e)ine greater than or equal to 15 mu mol/L] was higher in cerebrovascular patients with or without dementia than in normal control subjects (42.6%, 20.5%, and 10.1%, respectively; P=0.001). In contrast, a higher frequency of MTHFR TT genotype was found only in demented patients compared with nondemented patients and healthy controls (25.2%, 9.8%, and 12.0%, respectively; P=0.01). When the study subjects were divided into normohomocyst(e)inemic and hyperhomocyst(e)inemic groups, the TT genotype was significantly associated with the risk for vascular dementia in the hyperhomocyst(e)inemic group (odds ratio 4.13, 95% CI 2.18 to 7.85; P=0.03) but not in the normohomocyst(e)inemic group. Demented patients with multiple infarcts had a higher frequency of TT genotype (odds ratio 3.13, 95% CI 2.23 to 4.39; P=0.0007), whereas those with a single infarct did not (odds ratio 2.03, P=0.15). In contrast, there was no significant association of the TT genotype with multiple infarcts in hyperhomocyst(e)inemic stroke patients. Taken together. these findings indicate a possible role of MTHFR TT genotype combined with hyperhomocyst(e)inemia in the pathogenesis of vascular dementia. Similar to the relationship between homocystinuria due to severe MTHFR deficiency and severe cystathionine beta-synthase deficiency, the TT genotype of MTHFR in hyperhomocyst(e)inemic subjects is differentiated from the cases of the TT genotype without hyperhomocyst(e)inemia or hyperhomocyst(e)inemia without the TT genotype in the development of cerebrovascular disease.
引用
收藏
页码:1921 / 1925
页数:5
相关论文
共 27 条
[11]   DEMYELINATION AND DECREASED S-ADENOSYLMETHIONINE IN 5,10-METHYLENETETRAHYDROFOLATE REDUCTASE DEFICIENCY [J].
HYLAND, K ;
SMITH, I ;
BOTTIGLIERI, T ;
PERRY, J ;
WENDEL, U ;
CLAYTON, PT ;
LEONARD, JV .
NEUROLOGY, 1988, 38 (03) :459-462
[12]  
KANG SS, 1988, AM J HUM GENET, V43, P414
[13]  
KANG SS, 1992, ANNU REV NUTR, V12, P279, DOI 10.1146/annurev.nu.12.070192.001431
[14]  
Kang SS, 1997, DEV CARDIOVASC MED, P43
[15]   A common polymorphism in the methylenetetrahydrofolate reductase gene, homocysteine, and ischemic cerebrovascular disease [J].
Markus, HS ;
Ali, N ;
Swaminathan, R ;
Sankaralingam, A ;
Molloy, J ;
Powell, J .
STROKE, 1997, 28 (09) :1739-1743
[16]   Methylenetetrahydrofolate reductase gene polymorphism and ischemic stroke in Japanese [J].
Morita, H ;
Kurihara, H ;
Tsubaki, S ;
Sugiyama, T ;
Hamada, C ;
Kurihara, Y ;
Shindo, T ;
Oh-Hashi, Y ;
Kitamura, K ;
Yazaki, Y .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998, 18 (09) :1465-1469
[17]  
Mudd S.H., 1995, METABOLIC MOL BASIS, P1279
[18]   Hyperhomocysteinaemia - A common finding in a psychogeriatric population [J].
Nilsson, K ;
Gustafson, L ;
Faldt, R ;
Andersson, A ;
Brattstrom, L ;
Lindgren, A ;
Israelsson, B ;
Hultberg, B .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1996, 26 (10) :853-859
[19]  
Ou CY, 1996, AM J MED GENET, V63, P610, DOI 10.1002/(SICI)1096-8628(19960628)63:4<610::AID-AJMG15>3.0.CO
[20]  
2-L